These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8255902)
21. The effect of amperozide, a new antipsychotic drug, on plasma corticosterone concentration in the rat. Albinsson A; Andersson G Life Sci; 1992; 51(19):1535-44. PubMed ID: 1359366 [TBL] [Abstract][Full Text] [Related]
22. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization. Waters N; Pettersson G; Carlsson A; Svensson K Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):161-9. PubMed ID: 2572972 [TBL] [Abstract][Full Text] [Related]
23. Synthesis of dopamine and 5-HT in anatomical regions of the rat's brain is unaffected by sustained infusion of amperozide. Adell A; Myers RD Pharmacol Toxicol; 1995 Nov; 77(5):341-5. PubMed ID: 8778747 [TBL] [Abstract][Full Text] [Related]
24. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats. Schenk S Pharmacol Biochem Behav; 2000 Oct; 67(2):363-9. PubMed ID: 11124402 [TBL] [Abstract][Full Text] [Related]
31. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects. Svartengren J; Pettersson E; Björk A Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901 [TBL] [Abstract][Full Text] [Related]
32. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats. McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952 [TBL] [Abstract][Full Text] [Related]
33. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. Pehek EA; Meltzer HY; Yamamoto BK Eur J Pharmacol; 1993 Aug; 240(1):107-9. PubMed ID: 8405119 [TBL] [Abstract][Full Text] [Related]
34. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Ben-Shahar O; Keeley P; Cook M; Brake W; Joyce M; Nyffeler M; Heston R; Ettenberg A Brain Res; 2007 Feb; 1131(1):220-8. PubMed ID: 17161392 [TBL] [Abstract][Full Text] [Related]
35. Effects of dopamine D1 and D2 receptor antagonists on cocaine-induced place preference conditioning in preweanling rats. Pruitt DL; Bolanos CA; McDougall SA Eur J Pharmacol; 1995 Sep; 283(1-3):125-31. PubMed ID: 7498301 [TBL] [Abstract][Full Text] [Related]
37. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Neisewander JL; Lucki I; McGonigle P Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896 [TBL] [Abstract][Full Text] [Related]
38. Effects of amperozide on schedule-induced polydipsia in rats. Tung CS; Wu WH; Tseng CJ; Yin TH Eur J Pharmacol; 1994 Apr; 256(2):193-200. PubMed ID: 8050470 [TBL] [Abstract][Full Text] [Related]
39. The effects of amperozide on cocaine-induced social withdrawal in rats. Rademacher DJ; Kuppinger HE; Thompson KJ; Harrington A; Kaczmarek HJ; Kopish AJ; Steinpreis RE Behav Brain Res; 1999 Feb; 99(1):75-80. PubMed ID: 10512574 [TBL] [Abstract][Full Text] [Related]
40. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience. Kosten TA; Zhang XY; Kehoe P J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]